It was reported that microvesicles and exosomes released by tumor cells contribute to cancer immunosuppression by inducing, in T-cells, the transition from the effector phenotype (CD4+CD25−) to the regulator (CD4+CD25+Foxp3+) phenotype, its clonal expansion, and activation. This evidence concerns the gene CD4 and cancer.